World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
55
Citations
11507
World Ranking
12071
National Ranking
1909

Xinyong Liu publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Xinyong Liu sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 340 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Xinyong Liu D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Xinyong Liu sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 55 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Xinyong Liu is affiliated with Shandong University in China and has a substantial body of research output primarily in the fields of Medicine and Immunology and Microbiology. Their work focuses extensively on infectious diseases, virology, and molecular biology, intersecting with epidemiology and organic chemistry.

Their research topics encompass a range of areas including:

  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Click Chemistry and Applications
  • Hepatitis C virus research
  • Computational Drug Discovery Methods
  • Influenza Virus Research Studies

Liu has published in multiple scientific journals, with frequent appearances in:

  • Journal of Medicinal Chemistry (34 publications)
  • European Journal of Medicinal Chemistry (33 publications)
  • Molecules (9 publications)
  • Bioorganic & Medicinal Chemistry (8 publications)
  • International Journal of Molecular Sciences (7 publications)

Recent significant papers include:

  • "Fsp3: A new parameter for drug-likeness," 2020, Drug Discovery Today
  • "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling," 2020, Signal Transduction and Targeted Therapy
  • "Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities," 2020, Journal of Medicinal Chemistry
  • "Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses," 2021, Chemical Society Reviews
  • "SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules," 2022, Signal Transduction and Targeted Therapy

Liu collaborates frequently with a range of coauthors, notably:

  • Peng Zhan (112 joint papers)
  • Dongwei Kang (89 joint papers)
  • Christophe Pannecouque (68 joint papers)
  • Erik De Clercq (67 joint papers)
  • Shujing Xu (46 joint papers)

In addition to journal publications, Liu has contributed to book publications. One such work is titled "Antiviral Drug Discovery and Development," published in 2021 by Springer Nature, which has been cited in other research contexts.

Best Publications

  • Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends

    Peng Zhan;Christophe Pannecouque;Erik De Clercq;Xinyong Liu

  • Fsp3: A new parameter for drug-likeness.

    Wenxiu Wei;Srinivasulu Cherukupalli;Lanlan Jing;Xinyong Liu

  • HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and implications for drug design.

    Peng Zhan;Xuwang Chen;Dongyue Li;Zengjun Fang

  • Conformational restriction: an effective tactic in 'follow-on'-based drug discovery

    Zengjun Fang;Yu'ning Song;Peng Zhan;Qingzhu Zhang

  • 8-Hydroxyquinoline: a privileged structure with a broad-ranging pharmacological potential

    Yu'ning Song;Hao Xu;Wenmin Chen;Peng Zhan

  • Recent applications of click chemistry in drug discovery.

    Xiangyi Jiang;Xia Hao;Lanlan Jing;Gaochan Wu

  • Current drug research on PEGylation with small molecular agents

    Wenjun Li;Peng Zhan;Erik De Clercq;Hongxiang Lou

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.

    Yi Zheng;Meng Wei Zhuang;Lulu Han;Jing Zhang

  • Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities.

    Siyu Xiu;Alexej Dick;Han Ju;Sako Mirzaie

  • Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries.

    Xueshun Wang;Boshi Huang;Xinyong Liu;Peng Zhan

  • The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic

    Vigneshwaran Namasivayam;Murugesan Vanangamudi;Victor G. Kramer;Sonali Kurup

  • Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles.

    Dongwei Kang;Zengjun Fang;Zhenyu Li;Boshi Huang

  • Overview of Recent Strategic Advances in Medicinal Chemistry

    Gaochan Wu;Tong Zhao;Dongwei Kang;Jian Zhang

  • Strategies for the Design of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Lessons from the Development of Seven Representative Paradigms

    Dongyue Li;Peng Zhan;Erik De Clercq;Xinyong Liu

  • Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses

    Yue Ma;Estrella Frutos-Beltrán;Dongwei Kang;Christophe Pannecouque

  • 1,3,4-Oxadiazole: A Privileged Structure in Antiviral Agents

    Z. Li;P. Zhan;X. Liu

  • Recent advances in DAPYs and related analogues as HIV-1 NNRTIs.

    Xuwang Chen;Peng Zhan;Dongyue Li;Erik De Clercq

  • Design Strategies of Novel NNRTIs to Overcome Drug Resistance

    Peng Zhan;Xinyong Liu;Zhenyu Li;Christophe Pannecouque

  • Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants

    Dongwei Kang;Zengjun Fang;Boshi Huang;Xueyi Lu

  • Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: Optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches

    Boshi Huang;Cuicui Li;Wenmin Chen;Tao Liu

  • Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies

    Peng Zhan;Xinyong Liu;Zhenyu Li;Zengjun Fang

  • Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus.

    Ye Tian;Zhaoqiang Liu;Jinghan Liu;Boshi Huang

  • Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: Design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives

    Ye Tian;Deping Du;Diwakar Rai;Liu Wang

  • New techniques and strategies in drug discovery

    Jintong Du;Jing Guo;Dongwei Kang;Zhihong Li

Frequent Co-Authors

Peng Zhan
Peng Zhan Shandong University
Erik De Clercq
Erik De Clercq Rega Institute for Medical Research
Christophe Pannecouque
Christophe Pannecouque Rega Institute for Medical Research
Jan Balzarini
Jan Balzarini KU Leuven
Luis Menéndez-Arias
Luis Menéndez-Arias Spanish National Research Council
Chin Ho Chen
Chin Ho Chen Duke University
Kuo Hsiung Lee
Kuo Hsiung Lee University of Minnesota
Lieve Naesens
Lieve Naesens Rega Institute for Medical Research
Jacob Kongsted
Jacob Kongsted University of Southern Denmark
Hong Liu
Hong Liu Shandong University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Chemistry can open doors to diverse career pathways beyond traditional laboratory roles. For instance, understanding the cost of criminal justice degree programs offers perspective on investing in specialized education that complements chemical expertise, such as forensic science.

Many students start with foundational options like the online criminal justice associate degree programs, which can lead to roles in forensic analysis or regulatory compliance where chemistry knowledge is valuable.

Another related pathway involves legal support roles. Those interested in combining science with law might consider paralegal studies, noting the earning potential tied to an paralegal salary associate's degree.

Additionally, careers like pharmaceutical sales benefit from a chemistry background, with competitive compensation highlighted in discussions about pharmaceutical sales salary. This role blends scientific knowledge with communication and marketing skills.

Best Scientists Citing Xinyong Liu

Trending Scientists